RENAL DENERVATION FOR HYPERTENSION

Practice materials

Help more hypertension patients achieve control. Resources to bring the Symplicity™ blood pressure procedure to your practice.

Male HCP in blue scrubs and female HCP in white lab coat looking down at a tablet

Alert Indications, Safety, and Warnings

Start the transformation.

Provide your patients with a safe and effective complementary hypertension treatment option. Learn more about the Symplicity™ blood pressure procedure.

pdf The Symplicity Spyral™ renal denervation system brochure (.pdf)

The Symplicity Spyral renal denveration system brochure provides an overview of the procedure and the evidence that supports it, along with details on the system itself.

1.7MB

pdf Symplicity™ blood pressure procedure for referring physicians (.pdf)

Overview of clinical safety and efficacy data, patient selection criteria, and guideline support

1.5MB

A brochure explaining renal denervation for hypertension

Highlight hypertension risks.

Engage patients in a conversation about the health risks of hypertension with these ready-made materials.

Download patient awareness materials.

pdf Infographic (.pdf)

129KB

pdf Email template (.pdf)

4.8MB

pdf Web banner (.pdf)

35KB

mp4 “Global Health Crisis” video (.mp4)

2.6MB

pdf Poster (.pdf)

101KB

mp4 “Major Health Burden” video (.mp4)

1.6MB

xlsx Social posts (.xlsx)

142KB

mp4 “Expensive to Treat” video (.mp4)

1.5MB

Guidelines and consensus statements supporting renal denervation

Review patient guidelines for renal denervation, which includes the Symplicity blood pressure procedure, from medical societies around the world.

European Society of Hypertension (ESH)
ESH Hypertension guidelines recommend renal denervation Class II for uncontrolled hypertension patients.
European Society of Cardiology (ESC) Council on Hypertension and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
This consensus statement recommends renal denervation as an effective treatment option for uncontrolled resistant hypertension.^†

Taiwan Hypertension Society (THS) and Taiwan Society of Cardiology (TSC)
Consensus statement affirms renal denervation may benefit patients. This includes a patient selection tool.
Asia Renal Denervation Consortium (ARDeC)
Statement recommendations inform healthcare professionals on renal denervation, including five questions to ask upon consideration.

Explore education resources.

CME courses, peer presentations, training materials, and additional educational content

Find education

CONTACT

Request more information about the Symplicity blood pressure procedure.

Request info

Connect with a Medtronic representative.

Connect with rep

† Resistant hypertension is defined as uncontrolled office BP (≥ 140/≥ 90 mmHg), which is confirmed by out-of-office BP measurements, despite appropriate lifestyle changes and the intake of a triple-drug combination, including a diuretic at maximally tolerated doses.